Evidence map›Paper›PMID 30227649›Full record

ArticleHealthcare (Basel, Switzerland)2018

Provider's Perceptions of Barriers and Facilitators for Latinas to Participate in Genetic Cancer Risk Assessment for Hereditary Breast and Ovarian Cancer.

Alejandra Hurtado-de-Mendoza, Kristi Graves, Sara Gómez-Trillos, Lyndsay Anderson, Claudia Campos, Chalanda Evans, Selma Stearns, Qi Zhu, Nathaly Gonzalez, Vanessa B Sheppard

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Alejandra Hurtado-de-MendozaDepartment of Oncology, Georgetown University Medical Center, 3300 Whitehaven Street, Suite 4100, Washington, DC 20007, USA. ahd28@georgetown.edu.
Kristi GravesDepartment of Oncology, Georgetown University Medical Center, 3300 Whitehaven Street, Suite 4100, Washington, DC 20007, USA. kdg9@georgetown.edu.
Sara Gómez-TrillosDepartment of Oncology, Georgetown University Medical Center, 3300 Whitehaven Street, Suite 4100, Washington, DC 20007, USA. sg1328@georgetown.edu.
Lyndsay AndersonDepartment of Nursing, California State University, Sacramento, CA 95819-6096, USA. ltw7@georgetown.edu.
Claudia CamposNueva Vida, DC Office-Alexandria, 206 N. Washington St. Suite 300, Alexandria, VA 22314, USA. ccampos@nueva-vida.org.
Chalanda EvansPenn Medicine Nudge Unit, University of Pennsylvania, Philadelphia, PA 19104, USA. chaevansc3@gmail.com.
Selma StearnsDepartment of Oncology, Georgetown University Medical Center, 3300 Whitehaven Street, Suite 4100, Washington, DC 20007, USA. ss4081@georgetown.edu.
Qi ZhuDepartment of Oncology, Georgetown University Medical Center, 3300 Whitehaven Street, Suite 4100, Washington, DC 20007, USA. qz66@georgetown.edu.
Nathaly GonzalezCapital Breast Cancer Center, 1000 New Jersey Ave, SE, Washington, DC 20003, USA. ng472@georgetown.edu.
Vanessa B SheppardDepartment of Health Behavior Policy, Virginia Commonwealth University, Richmond, VA 23219, USA. Vanessa.Sheppard@vcuhealth.org.
Georgetown University · USCalifornia State University, Sacramento · USNueva Vida · USUniversity of Pennsylvania Health System · USVirginia Commonwealth University · US

Funding

Institutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5M
Enhancing at-Risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian CancerR03CA191543 · NCI · GEORGETOWN UNIVERSITY · PI HURTADO DE MENDOZA CASAUS, ALEJANDRA, SHEPPARD, VANESSA B · 2016 to 2017
$158k
Georgetown-Howard Universities Center for Clinical and Translational Science KL2TR001432National Cancer Institute R03CA191543NCATS NIH HHS KL2 TR001432NCI NIH HHS R03 CA191543
6 · The paper itself

Abstract

The Comprehensive Cancer Network (NCCN) recommends genetic cancer risk assessment (GCRA) referral to women at high risk of hereditary breast and ovarian cancer. Latinas affected by breast cancer have the second highest prevalence of

Indexed as

barriersgenetic counselinggenetic testinghereditary breast and ovarian cancerLatinasProvider’s perspectives

Identifiers

PMID30227649
PMCPMC6164735
OpenAlexW2890065657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.